DateNov. 21(Thu) 08:30~15:45
PlaceConrad Seoul Park Ballroom (5th floor), Conrad Seoul, Yeouido, Seoul, Korea
09:00~09:20 |
Opening |
Yeong seop Lee CEO, News1 |
09:20~09:50 |
Special LectureThe Present and Future of Bio Ventures in the Republic of Korea |
Soo Jin ChoiMember of the 22ndNational Assembly Republic of Korea |
09:50~10:20 |
Key note Speech ①Innovative and Bold research and development initiative in Biohealth |
Kyung SUNDirector General, K-Health MIRAE Initiative |
10:20~10:40 |
Key note Speech ②Strategy for Korea BioHealth Industry as Future Growth Engine |
Byung Geon (BG) RheeGI Innovation, Chairman & CEO |
10:40~11:00 |
BIO Trend ①R&D open innovation strategy and a story of development of 3rd-generation EGFR inhibitor for NSCLC |
Se-Woong OhVice President, Head of Research Institute, Yuhan Corporation |
11:00~11:20 |
BIO Trend ②Two Drugs, Two Different Journeys |
Hae In ShinVice President, Pipeline Value Up, SK Biopharmaceuticals |
11:20~12:00 |
Discussion |
Seung-kyou LeeVice President of KoreaBIO Byung Geon (BG) RheeGI Innovation, Chairman & CEO Se-Woong OhVice President, Head of Research Institute, Yuhan Corporation Hae In ShinVice President, Pipeline Value Up, SK Biopharmaceuticals Yeong Min ParkPresident & CEO Korea Drug Development Fund |
12:00~13:20 |
Lunch Time |
|
13:20~13:40 |
Key note Speech ③Guide to IPOs for Biotech companies |
Aaron Seo Director General, Technology Company Listing Review, Korea Exchange |
13:40~14:00 |
BIO Trend ③Framework of Pre-Submission Consultation for Innovative Products |
Heesung KimDirector of Pre-Submission Consultation Division, Korea Ministry of Food and Drug Safety |
14:00~14:45 |
IR Session |
Park, Joo CheolCEO, HysensBio Seong-Wook LeePresident & CEO, Rznomics Inc. Sung Kil TakDOF Inc. CFO&COO |
14:45~15:35 |
Discussion |
Myung Kee KimCEO, LSK Investment Aaron Seo Director General, Technology Company Listing Review, Korea Exchange Heesung KimDirector of Pre-Submission Consultation Division, Korea Ministry of Food and Drug Safety Soon ouk JungKorea Investment Partners, Director Young-Hun LeSenior Director,, LSK Investment Joo Cheol ParkCEO, HysensBio |
15:35~15:45 |
Q&A |
※ The above schedule is subject to change.